#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pericarditis Anaemia Lymphangiosarcoma Primary adrenal insufficiency Retinopathy proliferative Short-bowel syndrome Hyperinsulinism Carcinoid syndrome Congenital pseudarthrosis Haemophilia B without inhibitors Retinoblastoma B-cell small lymphocytic lymphoma refractory Hyperadrenocorticism Oesophageal atresia Human papilloma virus immunisation More trials…

    Learn about Rare Diseases

    Hereditary neuropathic amyloidosis – Trials in Disease Congenital generalised lipodystrophy – Diagnostics Haemophilia B without inhibitors – Life with Disease Osteosarcoma recurrent Brain stem glioma – Trials in Disease Rhabdoid tumour – Life with Disease Netherton’s syndrome – Life with Disease Prolymphocytic leukaemia – Treatment Antisynthetase syndrome – Life with Disease Rhabdomyosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Toripalimab Juniper Berry Oil Lansoprazole Myrrh Tigecycline Phenol, Liquefied Sodium Glycerophosphate NVG-2089 GSKVX000000070965 Izaflortaucipir (18F) Mitotane FLUORIDE Goserelin Syn321 Meclofenamate Sodium Ceritinib Clazakizumab Spiramycin Povidone Upadacitinib More therapies…

    Learn about Your Condition

    Septic shock Erythema multiforme Eczema Thrombosis Rhabdoid tumour of the kidney Polymyalgia rheumatica Hyperlipidaemia Cold urticaria Femoral hernia Retinitis pigmentosa Anxiety Lymphangioma Lichenoid keratosis Oedema Diabetes insipidus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hopitaux Universitaires Paris Centre-Hopital Cochin…

Hopitaux Universitaires Paris Centre-Hopital Cochin

123 Bd de Port Royal, Batiment Copernic 5eme etage Service Oncologie, Paris, Paris, France,, Paris, 75014, France

Want to learn more about this study or check if you can participate? Contact us.

  • Phase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer metastatic
    • Fallopian tube cancer
    • Ovarian cancer
    Investigated Drugs:
    • Mirvetuximab Soravtansine
    • LY4170156
    • Bevacizumab
    Austria Belgium Czechia Denmark France Germany +9

  • A Study Comparing PF-08046054 to Docetaxel in Adults with Previously Treated PD-L1 Positive Non-Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST PD-L1 CONJUGATED TO MONOMETHYL AURISTATIN E VIA A VALINE-CITRULLINE LINKER
    • Docetaxel
    Belgium Bulgaria Czechia Denmark Finland France +8

  • Study of fianlimab plus cemiplimab with chemotherapy or cemiplimab with chemotherapy for patients with pleural mesothelioma who have not received prior treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pleural mesothelioma
    Investigated Drugs:
    • Cemiplimab
    • Fianlimab
    France

  • Study of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Bulgaria Czechia France Germany Greece Hungary +3

  • Comparison of ceftriaxone and azithromycin versus amoxicillin and azithromycin for pregnant women with preterm premature rupture of membranes between 22 and 33 weeks.

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Abortion threatened
    Investigated Drugs:
    • Amoxicillin
    • Azithromycin
    • Ceftriaxone
    France

  • Study Comparing Selpercatinib with a Drug Combination for Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Selpercatinib
    • Carboplatin
    • Cisplatin
    Belgium France Germany Greece Italy The Netherlands +1

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!